Cargando…

Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge

IMPORTANCE: Vaccination against the SARS-CoV-2 virus is critical to control the pandemic. Randomized clinical trials demonstrated efficacy of the single-dose Ad26.COV2.S COVID-19 vaccine, but data on longer-term protection in clinical practice and effectiveness against variants are needed. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polinski, Jennifer M., Weckstein, Andrew R., Batech, Michael, Kabelac, Carly, Kamath, Tripthi, Harvey, Raymond, Jain, Sid, Rassen, Jeremy A., Khan, Najat, Schneeweiss, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931562/ https://www.ncbi.nlm.nih.gov/pubmed/35297969 http://dx.doi.org/10.1001/jamanetworkopen.2022.2959

Ejemplares similares

Durability of Protection Post–Primary COVID-19 Vaccination in the United States
por: Zheutlin, Amanda, et al.
Publicado: (2022)

SARS-CoV-2 Seroprevalence before Delta Variant Surge, Chattogram, Bangladesh, March–June 2021
por: Bhuiyan, Taufiqur Rahman, et al.
Publicado: (2022)

Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice
por: Mahrokhian, Shant H., et al.
Publicado: (2022)

Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers
por: Sablerolles, Roos S G, et al.
Publicado: (2022)

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
por: Barouch, Dan H., et al.
Publicado: (2021)

Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
por: Barouch, Dan H., et al.
Publicado: (2021)

Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study
por: Murk, William, et al.
Publicado: (2021)

Analyse d’ensemble des complications de la COVID-19 : étude d’auto-appariement pré- et post-exposition
por: Murk, William, et al.
Publicado: (2021)

DNA Polymerase Delta Exhibits Altered Catalytic Properties on Lysine Acetylation
por: Njeri, Catherine, et al.
Publicado: (2023)

Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India
por: Chakrabarti, Sasanka, et al.
Publicado: (2022)

Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccine
por: Sowell, Josiah, et al.
Publicado: (2021)

Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
por: Baden, Lindsey R., et al.
Publicado: (2021)

COVID-associated acute limb ischemia during the Delta surge and the effect of vaccines
por: Xie, Bowen, et al.
Publicado: (2023)

Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study
por: Bateman, Brian T, et al.
Publicado: (2013)

The impact of the COVID‐19 surge on phototherapy in Taiwan: Focusing on the patient profile, adherence, and attitude before and after the surge
por: Chu, Kuan‐Yu, et al.
Publicado: (2023)

Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India – Authors' reply
por: Thiruvengadam, Ramachandran, et al.
Publicado: (2022)

COVID-19–Associated Acute Limb Ischemia During the Delta Surge and Effect of Vaccines
por: Xie, Bowen, et al.
Publicado: (2022)

SURG-03. Durability of an Early Management Strategy Facilitating Endoscopic Removal of Recurrent Choroid Plexus Carcinoma
por: Guadix, Sergio, et al.
Publicado: (2022)

High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge
por: Ujjainiya, Rajat, et al.
Publicado: (2022)

Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials
por: Sadoff, Jerald, et al.
Publicado: (2022)

Increasing severity of COVID-19 in pregnancy with Delta (B.1.617.2) variant surge
por: Adhikari, Emily H., et al.
Publicado: (2022)

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques
por: Roozendaal, Ramon, et al.
Publicado: (2021)

Evaluation of Erlotinib in Advanced Non-Small Cell Lung Cancer: Impact on the Budget of a U.S. Health Insurance Plan
por: Ramsey, Scott D., et al.
Publicado: (2006)

Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection
por: Harvey, Raymond A., et al.
Publicado: (2020)

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
por: Harvey, Raymond A., et al.
Publicado: (2021)

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2021)

High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh
por: Hegde, Sonia T., et al.
Publicado: (2022)

Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases
por: Rassen, Jeremy A, et al.
Publicado: (2018)

Surge-type and surge-modified glaciers in the Karakoram
por: Bhambri, R., et al.
Publicado: (2017)

Reply to comment on “COVID-19 incidence and hospitalization during the delta surge were inversely related to vaccination coverage”
por: Harris, Jeffrey E.
Publicado: (2022)

The Baseline Seroprevalence of SARS-CoV-2 Before the Omicron Surge in Korean Children – The Calm Before the Perfect Storm
por: Jo, Dae Sun
Publicado: (2022)

515. Evolution of Treatment Patterns for Patients Hospitalized with COVID-19 in the United States
por: Zalocusky, Kelly, et al.
Publicado: (2021)

Delta-Sigma AD-Converters: Practical Design for Communication Systems
por: Gaggl, Richard
Publicado: (2013)

Anomalous chin lesion: The many presentations of extraosseous Ewing’s sarcoma
por: Shetty, Tripthi P., et al.
Publicado: (2022)

Hurricane Ida's impact on Louisiana and Mississippi during the COVID-19 Delta surge: Complex and compounding threats to population health
por: Shultz, James M., et al.
Publicado: (2022)

Impact of vaccination against the novel coronavirus infection (COVID-19) with Sputnik V on mortality during the delta variant surge
por: Dmitrieva, Ksenia, et al.
Publicado: (2023)

2485. Candida auris Hospital Cluster: Were Our Unwelcome Guests Driven Away by the COVID-19 Delta Surge?
por: Somani, Jyoti, et al.
Publicado: (2023)

Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers
por: Brunner, Wendy M., et al.
Publicado: (2022)

Surge Capacity
por: Casani, Julie Ann P., et al.
Publicado: (2006)

Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis
por: Bergman, Martin J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u9iqiboglhggdm6vdmb9p2105m